RCE 5.94% 53.5¢ recce pharmaceuticals ltd

[INTERVIEW] CEO buys another $300,000 stake in Recce Pharmaceuticals (ASX:RCE), page-24

  1. 7,301 Posts.
    lightbulb Created with Sketch. 1132
    No not 'all viruses' but 'in theory' all envelope viruses, as destroying the 'envelope' is the mode of action. FYI - a list below - Eboli isn't mentioned specificaly which is interesting as it is an envelope virus. Also the 'Bird flu' H5N1 etc which is decimating bird pollutions ATM, are envelope viruses, African swine fever, the list goes on.

    I do understand that getting a delivery mode to get at & kill these envelope viruses or bacteria for that matter, is the issue. Sure for tropical application there a plenty of options as yopu mention, bleach etc & ATM IV seems to be safe at high doses but gets washed out of the human system too quickly BUT hangs around in the bladder, thus the UTI trials.

    Interesting that IV & IM administration seems more effective in animal trials so maybe some hope there yet.

    The potential is truely massive & the need is growing. Can Recce get some of the action ? recently $306,000 of the COE's money says yes. We will just have to wait & see.

    https://en.wikipedia.org/wiki/Viral_envelope
    https://hotcopper.com.au/data/attachments/5429/5429803-752513bb9c8b2779b177c687f57bd75a.jpg
    .

 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.